{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:35:39Z","timestamp":1779924939582,"version":"3.53.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>FOLFOX therapy is the main chemotherapy regimen for colorectal cancer. Peripheral neuropathy, hematotoxicity, and digestive symptoms are known to be the most frequent adverse events. Hyperammonemia and lactic acidosis rarely occur simultaneously during treatment with FOLFOX therapy; the number of case reports is limited worldwide. We report a case of disturbance of consciousness, considered to be caused by hyperammonemia and lactic acidosis that occurred during treatment with mFOLFOX6 therapy that was administered as postoperative adjuvant treatment for rectal cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>This case was of a 71-year-old man who had been receiving oral treatment for chronic kidney disease and diabetes mellitus. Laparoscopic low anterior resection and artificial anal construction surgery were performed for stage III rectal cancer. As adjuvant postoperative therapy, mFOLFOX6 therapy was started but was followed by a disturbance of consciousness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Results of the blood tests revealed notable hyperammonemia (ammonia level, 1,163\u200a\u03bcg\/dl) and lactic acidosis (pH 7.207; lactate, 17.56\u200ammol\/L); however, imaging diagnosis did not reveal intracranial lesions that could cause disturbance of consciousness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>For hyperammonemia, branched-chain amino acid agents and Ringers solution supplementation were administered. For acidosis, 7% sodium hydrogen carbonate was administered as treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The disturbance of consciousness improved within 12\u200ahours of initiating the treatment, and the patient was discharged with no sequelae on 7th day after hospitalization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In patients with chronic kidney disease, FOLFOX regimen may confer risks of hyperammonemia and lactic acidosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021743","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T06:13:55Z","timestamp":1597299235000},"page":"e21743","source":"Crossref","is-referenced-by-count":8,"title":["Disturbance of consciousness due to hyperammonemia and lactic acidosis during mFOLFOX6 regimen"],"prefix":"10.1097","volume":"99","author":[{"given":"Masafumi","family":"Fukuda","sequence":"first","affiliation":[{"name":"Advanced Emergency and Critical Care Center, Kurume University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Nabeta","sequence":"additional","affiliation":[{"name":"Department of Emergency and Acute Intensive Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Muta","sequence":"additional","affiliation":[{"name":"Department of Emergency and Acute Intensive Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Cho","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Shimamatsu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Shimotsuura","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Fukami","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Takasu","sequence":"additional","affiliation":[{"name":"Department of Emergency and Acute Intensive Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/JCO.2004.05.113","article-title":"FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study","volume":"22","author":"Tournigand","year":"2004","journal-title":"J Clin Oncol"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.2004.11.037","article-title":"Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment","volume":"22","author":"Grothey","year":"2004","journal-title":"J Clin Oncol"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"de Gramont","year":"2000","journal-title":"J Clin Oncol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Multicenter international study of oxaliplatin\/5-fluorouracil\/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andr\u00e9","year":"2004","journal-title":"N Engl J Med"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2169\/internalmedicine.43.1009","article-title":"5-FU-induced acute leukoencephalopathy","volume":"43","author":"Ishibashi","year":"2004","journal-title":"Intern Med"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1200\/JCO.2007.13.5954","article-title":"Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin","volume":"25","author":"Pinedo","year":"2007","journal-title":"J Clin Oncol"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/bjc.1997.79","article-title":"High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy","volume":"75","author":"Yeh","year":"1997","journal-title":"Br J Cancer"},{"key":"R8-20230915","first-page":"2203","article-title":"Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile","volume":"47","author":"Heggie","year":"1987","journal-title":"Cancer Res"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3747\/co.v15i5.252","article-title":"The confused cancer patient: a case of 5-fluorouracil-induced encephalopathy","volume":"15","author":"Cheung","year":"2008","journal-title":"Curr Oncol"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jjco\/hyi214","article-title":"Intermediate dose 5-fluorouracil-induced encephalopathy","volume":"36","author":"Kim","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jjco\/hye130","article-title":"Weekly high-dose 5-fluorouracil (5-FU), leucovorin (LV) and bimonthly cisplatin in patients with advanced gastric cancer","volume":"31","author":"Lin","year":"2001","journal-title":"Jpn J Clin Oncol"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1200\/JCO.1988.6.10.1653","article-title":"Fluorouracil: biochemistry and pharmacology","volume":"6","author":"Pinedo","year":"1988","journal-title":"J Clin Oncol"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1378\/chest.06-2940","article-title":"Hyperammonemia in the ICU","volume":"132","author":"Clay","year":"2007","journal-title":"Chest"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"G189","DOI":"10.1152\/ajpgi.00165.2005","article-title":"Kidney plays a major role in ammonia homeostasis after portasystemic shunting in patients with cirrhosis","volume":"291","author":"Olde Damink","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00001813-199903000-00004","article-title":"Risk of transient hyperammonemic encephalopathy in cancer patients who received continuous infusion of 5-fluorouracil with the complication of dehydration and infection","volume":"10","author":"Liaw","year":"1999","journal-title":"Anticancer Drugs"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.anl.2007.04.012","article-title":"The aggravating factors of hyperammonemia related to 5-fluorouracil infusion--a report of two cases","volume":"35","author":"Kikuta","year":"2008","journal-title":"Auris Nasus Larynx"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMra1309483","article-title":"Lactic acidosis","volume":"371","author":"Kraut","year":"2014","journal-title":"N Engl J Med"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/jcp.30.1.92-d","article-title":"Clinical and biochemical aspects of lactic acidosis","volume":"30","author":"Robert","year":"1977","journal-title":"J Clin Pathol"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/ckj\/sfy012","article-title":"Type B lactic acidosis from fluorouracil in fluorouracil, oxaliplatin and leucovorin treatment for carcinoma of the colon in a hemodialysis patient","volume":"11","author":"Yeung","year":"2018","journal-title":"Clin Kidney J"},{"key":"R20-20230915","first-page":"1073","article-title":"Effect of the fluoropyrimidines 5-fluorouracil and doxifluridine on cellular uptake of thiamin","volume":"9","author":"Heier","year":"1989","journal-title":"Anticancer Res"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/0148607185009002216","article-title":"Severe acute metabolic acidosis (acute beriberi): an avoidable complication of total parenteral nutrition","volume":"9","author":"Velez","year":"1985","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ki.1986.62","article-title":"Lactic acidosis","volume":"29","author":"Madias","year":"1986","journal-title":"Kidney Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:16:07Z","timestamp":1694826967000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021743"}},"subtitle":["Case report"],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":22,"journal-issue":{"issue":"33","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021743","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]}}}